Clinical trial

Dosage and Efficacy of Probucol-induced apoE to Negate Cognitive Deterioration

NCT02707458

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-04-01

PhasePHASE1 / PHASE2

Study timeline

Study start (unknown)2016-04-01Date precision: month

Registry last updated2018-01-31

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Dementia of the Alzheimer Typeunresolved

Age-related Cognitive Declineunresolved

Mild Cognitive Impairment Due to Alzheimer Diseaseunresolved

Interventions

Sponsors & collaborators

Douglas Mental Health University Institutelead sponsor

Weston Brain Institutecollaborator

McGill Universitycollaborator

Mapped research locations

MontrealQuebec, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02707458 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.